Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Plos One|March 20, 2019
Hyaluronic acid/poly(ethylenimine) polyelectrolyte multilayer coatings for siRNA-mediated local gene silencingOlivia Koenig, Bernd Neumann, Christian Schlensak, et al.Journal of Tissue Engineering and Regenerative Medicine|July 4, 2009
Porcine EPCs downregulate stem cell markers and upregulate endothelial maturation markers during in vitro cultivationMeltem Avci-Adali, Andrea Nolte, Perikles Simon, et al.New Biotechnology|November 6, 2012
Modification of small interfering RNAs to prevent off-target effects by the sense strandAndrea Nolte, Kathrin Ott, Jacques Rohayem, et al.Oligonucleotides|May 16, 2009
Optimized basic conditions are essential for successful siRNA transfection into primary endothelial cellsAndrea Nolte, Claudia Raabe, Tobias Walker, et al.Journal of Materials Science. Materials in Medicine|June 1, 2014
Endotoxins affect diverse biological activity of chitosans in matters of hemocompatibility and cytocompatibilityAndrea Nolte, Susanne Hossfeld, Marcell Post, et al.Journal of Nucleic Acids|October 7, 2011
Small interfering RNA efficiently suppresses adhesion molecule expression on pulmonary microvascular endotheliumTobias Walker, Julian Siegel, Andrea Nolte, et al.Molecular Medicine (Cambridge, Mass.)|July 28, 2011
Small-interfering RNA-eluting surfaces as a novel concept for intravascular local gene silencingAndrea Nolte, Tobias Walker, Martina Schneider, et al.Journal of Biomaterials Applications|March 30, 2012
Impact of polyelectrolytes and their corresponding multilayers to human primary endothelial cellsAndrea Nolte, Susanne Hossfeld, Birgit Schroeppel, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 16, 2012
Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfectionTobias Walker, Andrea Nolte, Volker Steger, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2013
New aspects of gene-silencing for the treatment of cardiovascular diseasesOlivia Koenig, Tobias Walker, Nadja Perle, et al.Pageof 3